Table 3.
Heart rate (HR; beats/nun) and mean arterial pressure (MAP; mmHg) data during in vivo rat experiments of IPC.
| HR | MAP | HR | MAP | HR | MAP | HR | MAP | |
|---|---|---|---|---|---|---|---|---|
| Pre-Drug Baseline | 1′ Pre-Ischemia | 15′ Ischemia | 2h Reperfusion | |||||
| Veh Ctrl | 378 ± 3 | 115 ± 4 | 377 ± 3 | 114 ± 4 | 388 ± 4 | 107 ± 3 | 366 ± 5 | 85 ± 3* |
| Veh IPC1 | 377 ± 12 | 116 ± 7 | 378 ± 11 | 117 ± 6 | 397 ± 13 | 104 ± 14 | 373 ± 7 | 83 ± 5* |
| Veh IPC3 | 387 ± 18 | 110 ± 6 | 383 ± 15 | 109 ± 6 | 380 ± 10 | 95 ± 2 | 380 ± 12 | 78 ± 5* |
| ATL Ctrl | 370 ± 6 | 110 ± 3 | 363 ± 7 | 124 ± 4 | 365 ± 6 | 100 ± 4 | 355 ± 8 | 72 ± 4* |
| ATL IPC1 | 368 ± 5 | 103 ± 4 | 385 ± 9 | 121 ± 6 | 373 ± 9 | 87 ± 7 | 365 ± 14 | 78 ± 4* |
| ATL IPC3 | 390 ± 12 | 111 ± 6 | 390 ± 12 | 120 ± 5 | 377 ± 12 | 89 ± 7 | 380 ± 10 | 76 ± 6* |
P < 0.5 vs. respective pre-drug baseline value by repeated-measures ANOVA and Dunnett’s t test